Background: Patients with Diabetes Mellitus are more prone to Urinary tract infection (UTI) than non-diabetic patients. Diabetes Mellitus has certain negative effects on the genital system and increases the incidence of urinary tract infection in diabetic patients. Design: Record based retrospective study. Methods: Records of patients with type-II diabetes having symptoms of UTI were reviewed from August 2021 to January 2022. Result: Out of 210 diabetic patients, the UTI rate was higher in females 59% than male 41%. The most common agents for causing UTI were E.coli followed by Pseudomonas aeruginosa, Klebsiella spp., Candida albicans and Candida non-albicans, Enterococcus, S.aureus and other organisms. About 70.68% Gram-negative isolates were resistant against ampicillin, 75.17% resistant against gentamycin, and 48.16% resistant against amoxicillin-clavulanic acid. Gram-positive isolates were 83.33% resistant against penicillin and 83.33% resistant against ciprofloxacin. However, both gram-negative and gram-positive were susceptible to nitrofurantoin. The overall multidrug resistance was observed in 201 out of 210 (95.71%) bacterial and candiduria isolates, while 3.33% of the isolates were resistant to one only antibiotic. Conclusion: Most common etiological agent is E.coli with high drug resistance to ampicillin and susceptible to nitrofurantoin. Therefore, performing urine culture and regular monitoring of UTI is essential.
Background: This Retrospective Study was conducted by collecting patient records from the COVID-19 registry of Parul Sevasharm Hospital. The goal of this study was to investigate the risk and mortality of COVID-19 patients with Metabolic Syndrome especially during the second wave of pandemic. Methods: This Retrospective Study was conducted by collecting patient records from the COVID-19 registry of Parul Sevasharm Hospital. The record of COVID-19 patients admitted during the second wave of pandemic (April – June, 2021) were included and analyzed for Metabolic syndrome, Demographic characteristics and Clinical Outcomes. Comorbidities were classified into the following Groups: DM (having DM with or without comorbidities), only DM (having DM without other comorbidities); HT (having HT with or without other comorbidities), only HT (having HT without other comorbidities); CVD (having CVD with or without comorbidities), only CVD (having CVD without other comorbidities). Correlation analysis was also done for sub-groups of DM+CVD, CVD+HT, HT+DM, (with or without other comorbidities). Results: Among 994 Patients with COVID-19, 748/994 (75.25%) were discharged as cured and 246 (24.74%) succumbed to death. The mean age of the study population was 52.64±14.72, in which 366 (36.82%) were Females and 628/994 (63.57%) were Males.
Background: Clinical outcome of patients hospitalized with COVID-19 and acute kidney injury (AKI) are not well understood. The clinical significance of abnormal electrolytes and renal outcome in COVID-19 patients have been poorly documented. We aim to exhibit the electrolyte abnormalities, renal outcome and associated risk factors in hospitalized COVID-19 patients in rural tertiary care hospital in Vadodara district, Western India. Method: A hospital record based retrospective study was conducted. Total 994 patients hospitalized with COVID-19 between 1st April 2021 to 30th June 2021 and those meeting inclusion criteria were included for the analysis. The laboratory data of interest included electrolytes reports like Na+, K+, CL-, creatinine and blood urea. Result: Of the total hospitalized COVID-19 patients, 324 patients were eligible. For the criteria for suspected AKI - 279 (86.11%) and no AKI - 45 (13.88%) patients were found. Suspected AKI patients were classified into four conditions: 1) HYPERNATREMIA (14.33%); HYPERKALEMIA (2.15%); BCR ratio >20 (65.59%); HIGH Cl- (17.92%). Out of total AKI patients, (36.91%) died whereas (13.3%) patients died in no AKI group. All patients were provided antibiotics, steroids and anti-viral therapies irrespective of AKI status, which we presume might have contributed in high mortality among suspected AKI.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.